Vanguard Health Care ETF vs State Street XLV: Which Is the Better Buy for Investors in 2026?

The healthcare sector has been on a tear, with investors seeking to capitalize on its growth. Two prominent exchange-traded funds (ETFs) vying for attention are the State Street Health Care Select Sector SPDR ETF (XLV) and the Vanguard Health Care ETF (VHT). While both funds aim to capture the market’s healthcare giants, they differ significantly in terms of diversification, concentration risk, and performance.

Concentration vs. Breadth: The Vanguard Advantage

The Vanguard Health Care ETF’s broad approach has yielded a portfolio with 423 holdings, including small- and mid-sized firms that XLV ignores. This diversification reduces concentration risk and provides a more nuanced view of the sector. In contrast, XLV focuses on blue-chip healthcare giants, with only 2% allocated to small caps.

XLV’s reliance on large-cap stocks has its merits, particularly in times of market volatility. However, this focus contributes to a higher beta, making it more susceptible to price fluctuations. VHT’s style diversification, with 22% allocated to mid caps and 12% to small caps, offers a more balanced approach.

Performance: The Vanguard Edge

Over various time frames, the Vanguard Health Care ETF has consistently outperformed XLV, with returns of 8.9%, 5.1%, and 9.9% over the 3-, 5-, and 10-year periods, respectively. While XLV’s performance is not insignificant, its more concentrated portfolio inherently carries more risk.

Investing in a Volatile Market: Lessons from History

The Vanguard ETF’s superior performance is not solely due to its investment strategy. The fact that it has been able to outperform XLV over various time frames while maintaining a relatively low expense ratio speaks to the fund’s long-term potential. As investors navigate the complexities of the market, VHT offers a compelling case for those seeking steady growth and reduced concentration risk.

The Vanguard Health Care ETF’s emphasis on breadth and style diversification not only reduces concentration risk but also provides a more comprehensive view of the market. This nuanced approach is particularly valuable in the healthcare sector, where large-cap stocks often dominate the conversation. By considering smaller companies and mid caps, VHT offers investors an opportunity to tap into emerging trends and growth areas.

In conclusion, the Vanguard Health Care ETF’s edge over XLV makes it a more attractive choice for long-term investors seeking steady growth. Its emphasis on diversification, style diversity, and low expense ratio make it well-suited for those navigating the complexities of the healthcare sector.